UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms

Clinical cancer research, 2002-03, Vol.8 (3), p.718

2002

Volltextzugriff (PDF)

Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833

Journal of clinical oncology, 2001-02, Vol.19 (3), p.832-842

2001

Volltextzugriff (PDF)

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1621-1629

1994

Volltextzugriff (PDF)

Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy

Blood, 1999-07, Vol.94 (1), p.52-61

1999

Volltextzugriff (PDF)

Pilot Trial of the Safety, Tolerability, and Retinoid Levels of N-(4-hydroxyphenyl) Retinamide in Combination With Tamoxifen in Patients at High Risk for Developing Invasive Breast Cancer

Journal of clinical oncology, 2000-01, Vol.18 (2), p.275-283

2000

Volltextzugriff (PDF)

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

Journal of clinical oncology, 1995-02, Vol.13 (2), p.381-386

1995

Volltextzugriff (PDF)

Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer

Journal of clinical oncology, 1996-03, Vol.14 (3), p.774-782

1996

Volltextzugriff (PDF)

A Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction

Clinical cancer research, 2001-06, Vol.7 (6), p.1600-1609

2001

Volltextzugriff (PDF)

Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1173-1184

1996

Volltextzugriff (PDF)

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers

Cancer research (Chicago, Ill.), 1996-02, Vol.56 (3), p.569-573

1996

Volltextzugriff (PDF)

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer

Journal of clinical oncology, 1998-02, Vol.16 (2), p.635-641

1998

Volltextzugriff (PDF)

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

Clinical cancer research, 1999-09, Vol.5 (9), p.2381-2391

1999

Volltextzugriff (PDF)

A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignancies

Clinical cancer research, 1997-05, Vol.3 (5), p.755-760

1997

Volltextzugriff (PDF)

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma

Journal of clinical oncology, 1991-10, Vol.9 (10), p.1811-1820

1991

Volltextzugriff (PDF)

A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer

Cancer chemotherapy and pharmacology, 1995, Vol.35 (6), p.457-463

1995

Volltextzugriff (PDF)

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

Journal of clinical oncology, 1993-09, Vol.11 (9), p.1737-1745

1993

Volltextzugriff (PDF)

Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer

Investigational new drugs, 1993-02, Vol.11 (1), p.71-74

1993

Volltextzugriff (PDF)

A phase II study of continuous infusion 5‐fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma

Cancer, 1993-08, Vol.72 (3), p.663-668

1993

Volltextzugriff (PDF)

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients

Annals of oncology, 1994-10, Vol.5 (8), p.709-716

1994

Volltextzugriff (PDF)

Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction

Clinical cancer research, 1995-08, Vol.1 (8), p.797-803

1995

Volltextzugriff (PDF)

A Phase I Study of Paclitaxel and Cyclophosphamide in Recurrent Adenocarcinoma of the Ovary

Gynecologic oncology, 1996-06, Vol.61 (3), p.349-353

1996

Volltextzugriff (PDF)

A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (20), p.4828-4836

1993

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Adult
(23)
Humans
(23)
Life Sciences & Biomedicine
(23)
Middle Aged
(23)
Science & Technology
(23)
Female
(22)
Oncology
(21)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Antineoplastic Agents
(17)
Pharmacology. Drug Treatments
(17)
Male
(16)
Chemotherapy
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Drug Administration Schedule
(8)
Infusions, Intravenous
(8)
Paclitaxel - Administration & Dosage
(8)
Neoplasms - Drug Therapy
(7)
Administration, Oral
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms

Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion

Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy

Pilot Trial of the Safety, Tolerability, and Retinoid Levels of N-(4-hydroxyphenyl) Retinamide in Combination With Tamoxifen in Patients at High Risk for Developing Invasive Breast Cancer

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer

A Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction

Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignancies

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma

A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer

A phase II study of continuous infusion 5‐fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients

Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction

A Phase I Study of Paclitaxel and Cyclophosphamide in Recurrent Adenocarcinoma of the Ovary

A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma

Aktive Filter

Suchergebnisse filtern